OSCR

Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases.

Overview

Authors: S. Ozgul1,2,3, Z.F. Akpinar1,2, D. Suki4, P. Li1,2, Z. Majeed1,2, Y. Acikgoz1,2, S.D. Ferguson4, E. Jonasch5, M. Hasanov1,2, E. Hasanov1,2
  1. Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA
  2. Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA
  3. Department of Biostatistics and Medical Informatics, Suleyman Demirel University, Isparta, Turkey
  4. Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
  5. Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
Journal: ESMO open, volume 11, issue 8, article 108300
Dates: published online 30 July 2026; in print August 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.esmoop.2026.108300 · PMID 42531803 · PMCID PMC13452353 · OpenAlex W7171867770
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: human (organism), other condition (population), clinical / translational (subfield)
Methods: Connectivity, Machine learning, Statistics, Preprocessing
Keywords: machine learning, AI, RCC, brain metastases, immunotherapy, prognosis
MeSH: Brain Neoplasms*, Carcinoma, Renal Cell*, Kidney Neoplasms*, Machine Learning*, Aged, Female, Humans, Male, Middle Aged, Predictive Learning Models, Prognosis, Retrospective Studies (* major topic)
Topic: Brain Metastases and Treatment (Oncology, Medicine), according to OpenAlex
Funding: American Society of Clinical Oncology (ASCO); Conquer Cancer Foundation Young Investigator; International Kidney Cancer Coalition Cecile; Kidney Cancer Association Young Investigator
Citations: not cited yet (Europe PMC); 23 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

Code availability statement

The paper has a code availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.esmoop.2026.108300.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.esmoop.2026.108300.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added M. Hasanov (0000-0002-7195-0842); removed M. Hasanov

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 6 keywords, 12 MeSH terms, 4 funders, 21 references.

Cite

This paper

Ozgul, S., Akpinar, Z., Suki, D., Li, P., Majeed, Z., Acikgoz, Y., Ferguson, S., Jonasch, E., Hasanov, M., & Hasanov, E. (2026). Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases. ESMO open, 11(8), 108300. https://doi.org/10.1016/j.esmoop.2026.108300

BibTeX

@article{ozgul2026era,
author = {Ozgul, S. and Akpinar, Z.F. and Suki, D. and Li, P. and Majeed, Z. and Acikgoz, Y. and Ferguson, S.D. and Jonasch, E. and Hasanov, M. and Hasanov, E.},
title = {{Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases}},
journal = {ESMO open},
year = {2026},
month = jul,
volume = {11},
number = {8},
pages = {108300},
publisher = {Elsevier},
issn = {2059-7029},
doi = {10.1016/j.esmoop.2026.108300},
url = {https://doi.org/10.1016/j.esmoop.2026.108300},
pmid = {42531803},
pmcid = {PMC13452353}
}

RIS

TY - JOUR
AU - Ozgul, S.
AU - Akpinar, Z.F.
AU - Suki, D.
AU - Li, P.
AU - Majeed, Z.
AU - Acikgoz, Y.
AU - Ferguson, S.D.
AU - Jonasch, E.
AU - Hasanov, M.
AU - Hasanov, E.
TI - Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases
T2 - ESMO open
J2 - ESMO Open
PY - 2026
DA - 2026/07/30
VL - 11
IS - 8
SP - 108300
SN - 2059-7029
PB - Elsevier
DO - 10.1016/j.esmoop.2026.108300
UR - https://doi.org/10.1016/j.esmoop.2026.108300
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.esmoop.2026.108300",
"type": "article-journal",
"title": "Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases",
"container-title": "ESMO open",
"author": [
{
"family": "Ozgul",
"given": "S."
},
{
"family": "Akpinar",
"given": "Z.F."
},
{
"family": "Suki",
"given": "D."
},
{
"family": "Li",
"given": "P."
},
{
"family": "Majeed",
"given": "Z."
},
{
"family": "Acikgoz",
"given": "Y."
},
{
"family": "Ferguson",
"given": "S.D."
},
{
"family": "Jonasch",
"given": "E."
},
{
"family": "Hasanov",
"given": "M."
},
{
"family": "Hasanov",
"given": "E."
}
],
"container-title-short": "ESMO Open",
"volume": "11",
"issue": "8",
"page": "108300",
"DOI": "10.1016/j.esmoop.2026.108300",
"PMID": "42531803",
"PMCID": "PMC13452353",
"ISSN": "2059-7029",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.esmoop.2026.108300",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
30
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/noajnl/vdag140
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patients.
Journal: Neuro-oncology advances
In common: clinical / translational, other condition, 2 references, 2 authors
[2] doi:10.3390/cancers15051393
Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study.
Journal: Cancers
In common: clinical / translational, other condition, 2 references
[3] doi:10.7150/jca.103847
Machine Learning-based Prognostic Model for Brain Metastasis Patients: Insights from Blood Test Analysis.
Journal: Journal of Cancer
In common: clinical / translational, other condition, 1 reference
[4] doi:10.1186/s40001-023-01550-4
Differentiation between cerebral alveolar echinococcosis and brain metastases with radiomics combined machine learning approach.
Journal: European journal of medical research
In common: clinical / translational, other condition, 1 reference
[5] doi:10.3390/cancers14061475
Efficient Radiomics-Based Classification of Multi-Parametric MR Images to Identify Volumetric Habitats and Signatures in Glioblastoma: A Machine Learning Approach.
Journal: Cancers
In common: clinical / translational, other condition, 1 reference
[6] doi:10.1093/noajnl/vdac054
Glioma and the gut-brain axis: opportunities and future perspectives.
Journal: Neuro-oncology advances
In common: clinical / translational, other condition, 1 reference
[7] doi:10.3390/diagnostics13183007
A Review of Recent Advances in Brain Tumor Diagnosis Based on AI-Based Classification.
Journal: Diagnostics (Basel, Switzerland)
In common: clinical / translational, other condition, 1 reference
[8] doi:10.3389/fphar.2022.1072253
Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy.
Journal: Frontiers in pharmacology
In common: other condition, 1 reference
[9] doi:10.3389/fonc.2026.1816015 [code]
Modality-level attribution and redundancy-aware radiomics for MRI-based differentiation of melanoma and NSCLC brain metastases.
Journal: Frontiers in oncology
In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.